These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22430414)

  • 1. [Diagnostic problem - heart failure with preserved ejection fraction].
    Kilian N; Wlazłowski R
    Kardiol Pol; 2012; 70(3):282-6. PubMed ID: 22430414
    [No Abstract]   [Full Text] [Related]  

  • 2. Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications.
    Tanase DM; Radu S; Al Shurbaji S; Baroi GL; Florida Costea C; Turliuc MD; Ouatu A; Floria M
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31142058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-site-frequency electromechanocardiography for the prediction of ejection fraction and stroke volume in heart failure.
    Skrabal F; Mayer H; Hopfgartner E; Gratze G; Haitchi G; Holler A
    Eur J Heart Fail; 2005 Oct; 7(6):974-83. PubMed ID: 16227136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure with preserved ejection fraction: invasive solution to diagnostic confusion?
    Lam CS
    J Am Coll Cardiol; 2010 Apr; 55(16):1711-2. PubMed ID: 20394875
    [No Abstract]   [Full Text] [Related]  

  • 6. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence.
    Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM
    Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-123-metaiodobenzylguanidine imaging can predict future cardiac events in heart failure patients with preserved ejection fraction.
    Katoh S; Shishido T; Kutsuzawa D; Arimoto T; Netsu S; Funayama A; Ishino M; Niizeki T; Nishiyama S; Takahashi H; Miyashita T; Miyamoto T; Nitobe J; Watanabe T; Kubota I
    Ann Nucl Med; 2010 Nov; 24(9):679-86. PubMed ID: 20824398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical biochemistry: heart hormones. The Danish Society of Biochemistry].
    Gøtze JP; Rehfeld JF
    Ugeskr Laeger; 2004 Mar; 166(12):1109. PubMed ID: 15067768
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic and prognostic significance of plasma N-terminal-pro-brain natriuretic peptide in decompensated heart failure with preserved ejection fraction.
    Paul B; Soon KH; Dunne J; De Pasquale CG
    Heart Lung Circ; 2008 Dec; 17(6):497-501. PubMed ID: 18722158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure with a normal ejection fraction.
    Sanderson JE
    Heart; 2007 Feb; 93(2):155-8. PubMed ID: 16387829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The year in heart failure.
    Tang WH; Francis GS
    J Am Coll Cardiol; 2010 Feb; 55(7):688-96. PubMed ID: 20170796
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction.
    Carrasco-Sánchez FJ; Galisteo-Almeda L; Páez-Rubio I; Martínez-Marcos FJ; Camacho-Vázquez C; Ruiz-Frutos C; Pujol-De La Llave E
    J Card Fail; 2011 Jan; 17(1):31-8. PubMed ID: 21187262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An independent prognostic factor for heart failure: sympathetic hyperactivity.
    Kardesoglu E; Isilak Z; Uz O; Yiginer O
    Chin Med J (Engl); 2011 Apr; 124(7):1118. PubMed ID: 21542980
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of the pulmonary vasculature in heart failure with preserved ejection fraction.
    Lewis GD
    J Am Coll Cardiol; 2009 Mar; 53(13):1127-9. PubMed ID: 19324257
    [No Abstract]   [Full Text] [Related]  

  • 15. Heart rate predicts mortality in patients with heart failure and preserved systolic function.
    Kapoor JR; Heidenreich PA
    J Card Fail; 2010 Oct; 16(10):806-11. PubMed ID: 20932462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of heart failure with preserved ejection fraction: back to the drawing board?
    Dalzell JR; Jackson CE
    Heart; 2010 Jan; 96(1):72-3; author reply 73. PubMed ID: 20019210
    [No Abstract]   [Full Text] [Related]  

  • 17. Highly sensitive cardiac troponin T in heart failure: comparison with echocardiographic parameters and natriuretic peptides.
    Kusumoto A; Miyata M; Kubozono T; Ikeda Y; Shinsato T; Kuwahata S; Fujita S; Takasaki K; Yuasa T; Hamasaki S; Tei C
    J Cardiol; 2012 Mar; 59(2):202-8. PubMed ID: 22266455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis of heart failure with normal ejection fraction--a demanding task!
    Maeder MT; Ammann P; Rickli H
    Swiss Med Wkly; 2010 May; 140(21-22):323; author reply 324. PubMed ID: 20512707
    [No Abstract]   [Full Text] [Related]  

  • 19. Congestive heart failure in the elderly: comparison between reduced ejection fraction and preserved ejection fraction.
    Satomura H; Wada H; Sakakura K; Kubo N; Ikeda N; Sugawara Y; Ako J; Momomura S
    J Cardiol; 2012 Mar; 59(2):215-9. PubMed ID: 22266459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is cardiac resynchronization therapy an option in heart failure patients with preserved ejection fraction? Justification for the ongoing KaRen project.
    Donal E; Lund L; Linde C; Daubert JC;
    Arch Cardiovasc Dis; 2010; 103(6-7):404-10. PubMed ID: 20800804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.